Skip to main navigation Skip to search Skip to main content

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participa

Project: Research

Project Details

StatusActive
Effective start/end date04/10/23 → 01/23/27

Funding

  • Novartis Pharmaceuticals Corporation: $37,311.00